Protein kinase C upregulates intercellular adhesion molecule-1 and leukocyte-endothelium interactions in hyperglycemia via activation of endothelial expressed calpain.
Protein kinase C upregulates intercellular adhesion molecule-1 and leukocyte-endothelium interactions in hyperglycemia via activation of endothelial expressed calpain.
复制标题
DOI:
10.1161/atvbaha.110.217901
复制
发表时间:
2011-02
期刊:
影响因子:
--
通讯作者:
Scalia R
中科院分区:
文献类型:
--
作者:
Smolock AR;Mishra G;Eguchi K;Eguchi S;Scalia R
We tested the hypothesis of a role for the calcium-dependent protease calpain in the endothelial dysfunction induced by hyperglycemic activation of protein kinase C (PKC). Chronic hyperglycemia with insulin deficiency (Type-1 diabetes) was induced in rats by streptozotocin. Total PKC and calpain activities, along with activity and expression level of the two endothelial-expressed calpains isoforms, µ- and m-calpain, were measured in vascular tissue homogenates by enzymatic assays and western blot analysis, respectively. Intravital microscopy was used to measure and correlate leukocyte-endothelium interactions with calpain activity in the microcirculation. Expression levels and endothelial localization of the inflammatory adhesion molecule ICAM-1 were studied by western blot analysis and immunofluorescence, respectively. The mechanistic role of hyperglycemia alone in the process of PKC-induced calpain activation and actions was also investigated. We found that in the Type-1 diabetic vasculature PKC selectively upregulates the activity of the µ-calpain isoform. Mechanistic studies confirmed a role for hyperglycemia and PKCβ in this process. The functional implications of PKC-induced calpain activation were upregulation of endothelial expressed ICAM-1 and leukocyte-endothelium interactions. Our results uncover the role of µ-calpain in the endothelial dysfunction of PKC. Calpain may represent a novel molecular target for the treatment of PKC-associated diabetic vascular disease.